Related Experiment Video

Updated: Aug 15, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

[Prophylaxis of myocardial infarction and follow-up treatment (author's transl)]

P Lichtlen

    Arzneimittel-Forschung
    |January 1, 1977
    PubMed

    Insights

    Preventing myocardial infarction involves managing coronary artery disease risk factors and treating early ischemic heart disease. Post-infarction care focuses on symptom management and potentially life-threatening arrhythmias.

    Area of Science:

    • Cardiology
    • Preventive Medicine

    Context:

    • Myocardial infarction (MI) lacks specific prophylaxis, aligning with coronary artery disease (CAD) prevention strategies.
    • Management involves risk factor elimination and early treatment of ischemic heart disease.

    Purpose:

    • To outline the comprehensive management and prophylaxis strategies for myocardial infarction.
    • To highlight the importance of risk factor modification and timely intervention.

    Summary:

    • Prophylaxis for MI is synonymous with CAD prevention, emphasizing risk factor reduction and pre-infarction ischemic heart disease treatment.
    • Post-MI care is symptom-driven, with critical attention to diagnosing and managing potentially fatal arrhythmias, possibly requiring prophylactic antiarrhythmic therapy.
    • The role of clinical rehabilitation remains under discussion, while surgical interventions like aneurysmectomy and revascularization are gaining prominence.

    Impact:

    • Informs clinical practice regarding MI prevention and management.
    • Guides therapeutic decisions for post-MI patients, including arrhythmia management and surgical options.
    • Contributes to understanding the evolving landscape of cardiac care and rehabilitation.

    More Related Videos

    A Modified Simple Method for Induction of Myocardial Infarction in Mice04:29

    A Modified Simple Method for Induction of Myocardial Infarction in Mice

    Published on: December 3, 2021

    Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

    Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

    Published on: May 26, 2023

    Related Concept Videos

    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    Myocarditis IV: Nursing Management01:22

    Myocarditis IV: Nursing Management

    Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...